182 related articles for article (PubMed ID: 35474550)
1. Stem cell transplantation patients receiving a novel oral care protocol for oral mucositis prevention and treatment: patient-reported outcomes and quality of life.
Guberti M; Botti S; Fusco A; Caffarri C; Cavuto S; Savoldi L; Serra N; Merli F; Piredda M; De Marinis MG
Support Care Cancer; 2022 Jul; 30(7):6317-6325. PubMed ID: 35474550
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a colostrum- and Aloe vera-based oral care protocol to prevent and treat severe oral mucositis in patients undergoing hematopoietic stem cell transplantation: a single-arm phase II study.
Guberti M; Botti S; Caffarri C; Cavuto S; Savoldi L; Fusco A; Merli F; Piredda M; De Marinis MG
Ann Hematol; 2022 Oct; 101(10):2325-2336. PubMed ID: 35922679
[TBL] [Abstract][Full Text] [Related]
3. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
[TBL] [Abstract][Full Text] [Related]
4. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
[TBL] [Abstract][Full Text] [Related]
5. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).
Vitale MC; Modaffari C; Decembrino N; Zhou FX; Zecca M; Defabianis P
Lasers Med Sci; 2017 Aug; 32(6):1423-1428. PubMed ID: 28664389
[TBL] [Abstract][Full Text] [Related]
6. Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT).
Stiff PJ; Erder H; Bensinger WI; Emmanouilides C; Gentile T; Isitt J; Lu ZJ; Spielberger R
Bone Marrow Transplant; 2006 Feb; 37(4):393-401. PubMed ID: 16415901
[TBL] [Abstract][Full Text] [Related]
7. Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial.
Kamsvåg T; Svanberg A; Legert KG; Arvidson J; von Essen L; Mellgren K; Toporski J; Winiarski J; Ljungman G
Support Care Cancer; 2020 Oct; 28(10):4869-4879. PubMed ID: 31993753
[TBL] [Abstract][Full Text] [Related]
8. Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.
Legert KG; Remberger M; Ringdén O; Heimdahl A; Dahllöf G
Support Care Cancer; 2014 Aug; 22(8):2133-40. PubMed ID: 24647488
[TBL] [Abstract][Full Text] [Related]
9. Window therapeutic of extraoral photobiomodulation for prevention of oral mucositis in HSCT patients: additional arm.
da Cruz Santos LB; Ramos-Pinto MB; Zerbato RM; Ferreira MEMG; Schmidt-Filho J; Martins MD; Alves FA
Support Care Cancer; 2023 Dec; 32(1):27. PubMed ID: 38097854
[TBL] [Abstract][Full Text] [Related]
10. Burden of oral mucositis in stem cell transplant patients-the patients' perspective.
Staudenmaier T; Cenzer I; Crispin A; Ostermann H; Berger K
Support Care Cancer; 2018 May; 26(5):1577-1584. PubMed ID: 29197961
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Sakellari I; Angelopoulou M; Tsopra O; Dervenoulas I; Tsirigotis P; Spyridonidis A; Liga M; Tsionos K; Anargyrou K; Pouli A; Anagnostopoulos A
Ann Hematol; 2015 Oct; 94(10):1733-40. PubMed ID: 26141369
[TBL] [Abstract][Full Text] [Related]
12. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
[TBL] [Abstract][Full Text] [Related]
13. Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation.
Treister N; Nieder M; Baggott C; Olson E; Chen L; Dang H; Krailo M; August A; Sung L
Br J Cancer; 2017 Jan; 116(1):21-27. PubMed ID: 27875526
[TBL] [Abstract][Full Text] [Related]
14. Incidence, severity, and temporal development of oral complications in pediatric allogeneic hematopoietic stem cell transplant patients - a multicenter study.
Agholme MB; Dahllöf G; Törlén JK; Majorana A; Brennan MT; von Bültzingslöwen I; Tan PL; Hu S; Sim YF; Hong C
Support Care Cancer; 2023 Nov; 31(12):702. PubMed ID: 37971651
[TBL] [Abstract][Full Text] [Related]
15. A randomised trial of topical polaprezinc to prevent oral mucositis in patients undergoing haematopoietic stem cell transplantation (ToPaZ study).
Nakagaki M; Kennedy GA; Gavin NC; Butler J; Clavarino A; Whitfield K
Support Care Cancer; 2023 Dec; 32(1):44. PubMed ID: 38112867
[TBL] [Abstract][Full Text] [Related]
16. Oral mucositis in patients receiving reduced-intensity regimens for allogeneic hematopoietic cell transplantation: comparison with conventional regimen.
Takahashi K; Soga Y; Murayama Y; Udagawa M; Nishimoto H; Sugiura Y; Maeda Y; Tanimoto M; Takashiba S
Support Care Cancer; 2010 Jan; 18(1):115-9. PubMed ID: 19387694
[TBL] [Abstract][Full Text] [Related]
17. Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation.
Fall-Dickson JM; Ramsay ES; Castro K; Woltz P; Sportés C
Clin Ther; 2007; 29 Suppl():2547-61. PubMed ID: 18164921
[TBL] [Abstract][Full Text] [Related]
18. The effects of a combination oral spray (Mucosamin®) for the prevention of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: a double blind randomized clinical trial.
Shahrabi M; Solduzian M; Babaie MH; Mousavi SA; Goodarzi N; Ravari NS; Sadeghi K
Support Care Cancer; 2022 Oct; 30(10):7963-7972. PubMed ID: 35732749
[TBL] [Abstract][Full Text] [Related]
19. Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation.
Nguyen DT; Shayani S; Palmer J; Dagis A; Forman SJ; Epstein J; Spielberger R
Support Care Cancer; 2015 Nov; 23(11):3141-7. PubMed ID: 25791390
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin oral suspension in prevention and management of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized controlled trial.
Parkhideh S; Zeraatkar M; Moradi O; Hajifathali A; Mehdizadeh M; Tavakoli-Ardakani M
Support Care Cancer; 2022 Jan; 30(1):251-257. PubMed ID: 34259920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
